logo
logo
Sign in

How has the COVID-19 pandemic affected clinical trial research?

avatar
Anushree Reddy

Outside of vaccine trials, COVID-19 has had a significant impact on study participation. Most researchers have been trying to find ways to make it easier for patients to participate in studies with a minimum of in-person visits to the study center. We’re leveraging technology as much as we can so that patients can fill out questionnaires and sign informed consent documents from the comfort of their home. For visits that must be done in person, we’re being proactive to help patients safely navigate research visits. We’re ensuring that they have safe spaces for waiting, that they’re distanced from other people, that they’re wearing masks, and that everyone is doing their part to maintain a safe environment. The trial I’m currently working on, called C-TRACT, now allows some visits to be done remotely when needed and I think patients appreciate that. 

Clinical Research Training studies are always in need of volunteers. Without these volunteers, medications and treatments cannot be approved by the concerned authorities and thus cannot reach the patients.  Apart from gaining access to a potential treatment for a particular disease, other perks include receiving care at the topmost facilities, helping science, and making a potential impact on all those living in that particular condition. These studies generally offer generous compensation for your participation.As the best clinical research courses based on clinical trials strive to investigate if a potential treatment is both safe and effective, there is a certain level of risk associated with it.  When the recruited volunteers are chosen, there is a possibility that the treatment shall not be effective, and the volunteer can also be subjected to certain side-effects.

 

Why does it take so long to get new vaccines and medicines to market?
 
It is not a new question. But as governments, communities and medical professionals around the world focus their energy and resources on containing the COVID-19 pandemic, it’s being asked with increasing urgency. It deserves—in fact, it requires—our collective attention and effort.
 
The good news amidst so many troubling headlines is that the technologies we need to improve patient access and experience are here now. The smart application of those technologies can overcome barriers to trial execution and improve data sharing and process efficiency across organizations. Most urgently, those technologies can be used immediately to ensure progress for thousands of clinical trials in an environment where patients are expected to stay at home.

Conclusion

Clinical research trainings are given to every professional involved in the trial. Clinical research trainings are continuously updated based on the disease and development of technology to ensure the complete safety of the participants of the trial.

 

collect
0
avatar
Anushree Reddy
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more